_id
6915f853bc934aba376b2576
Ticker
SHPH
Name
Shuttle Pharmaceuticals Inc
Exchange
NASDAQ
Address
401 Professional Drive, Gaithersburg, MD, United States, 20879
Country
USA
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Currency
USD
Website
https://www.shuttlepharma.com
Description
Shuttle Pharmaceuticals Holdings, Inc., a clinical stage pharmaceutical company, develops novel therapies to cure cancers. The company is developing Ropidoxuridine, an oral halogenated pyrimidine to treat patients with brain tumors and sarcomas; and SP-2-225, a pre-clinical class IIb product candidate that effects on the regulation of the immune system. It is also developing SP-1-303, a pre-clinical selective Class I HDAC for use in the treatment of ER positive breast cancers; and SP-1-161, a HDAC inhibitor that initiates the mutated in ataxia-telangiectasia response pathway. The company was founded in 2012 and is headquartered in Gaithersburg, Maryland.
Last Close
2
Volume
65709
Current Price
1.48
Change
-0.07
Last Updated
2026-01-07T11:43:48.355Z
Image
data:image/webp;base64,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
Ipo Date
2022-08-31T00:00:00.000Z
Market Cap
3789848
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
-
Sentiment Sources
0
Current Quarter
2025-09-30
Revenue
0
Cost Of Revenue
1008
Gross Profit
-1008
Operating Expenses
2265934
Operating Income
-2266942
Interest Expense
18904
Pretax Income
-2347302
Net Income
-2347302
Eps
-1.050881740648714
Dividends Per Share
0
Shares Outstanding
1923781
Income Tax Expense
-
EBITDA
-2327390
Operating Margin
-
Total Other Income Expense Net
-80360
Cash
2094643
Short Term Investments
-
Receivables
-
Inventories
-
Total Current Assets
3265913
Property Plant Equipment
246709
Total Assets
3542927
Payables
1472897
Short Term Debt
492013
Long Term Debt
-
Total Liabilities
2148766
Equity
1394161
Bs_currency_symbol
USD
Depreciation
1008
Change In Working Capital
-467322
Cash From Operations
-2626654
Capital Expenditures
4
Cash From Investing
-
Cash From Financing
-96375
Net Change In Cash
-2723029
Cf_currency_symbol
USD
PE
-
PB
2.371176643156709
ROE
-168.3666377125741
ROA
-66.25318557226836
FCF
-2626658
Fcf Percent
-
Piotroski FScore
0
Health Score
32
Deep Value Investing Score
3.5
Defensive Investing Score
5.5
Dividend Investing Score
1.5
Economic Moat Investing Score
3.3
Garp Investing Score
1
Growth Investing Score
0.5
Momentum Investing Score
2.5
Net Net Investing Score
3
Quality Investing Score
2
Value Investing Score
3
Quarters > 0 > quarter
2025-09-30
Quarters > 0 > income Statement > revenue
0
Quarters > 0 > income Statement > cost Of Revenue
1008
Quarters > 0 > income Statement > gross Profit
-1008
Quarters > 0 > income Statement > operating Expenses
2265934
Quarters > 0 > income Statement > operating Income
-2266942
Quarters > 0 > income Statement > interest Expense
18904
Quarters > 0 > income Statement > pretax Income
-2347302
Quarters > 0 > income Statement > net Income
-2347302
Quarters > 0 > income Statement > eps
-1.050881740648714
Quarters > 0 > income Statement > dividends Per Share
0
Quarters > 0 > income Statement > shares Outstanding
2233650
Quarters > 0 > income Statement > income Tax Expense
-
Quarters > 0 > income Statement > EBITDA
-2327390
Quarters > 0 > income Statement > operating Margin
-
Quarters > 0 > income Statement > total Other Income Expense Net
-80360
Quarters > 0 > income Statement > currency_symbol
USD
Quarters > 0 > balance Sheet > cash
2094643
Quarters > 0 > balance Sheet > short Term Investments
-
Quarters > 0 > balance Sheet > receivables
-
Quarters > 0 > balance Sheet > inventories
-
Quarters > 0 > balance Sheet > total Current Assets
3265913
Quarters > 0 > balance Sheet > property Plant Equipment
246709
Quarters > 0 > balance Sheet > total Assets
3542927
Quarters > 0 > balance Sheet > payables
1472897
Quarters > 0 > balance Sheet > short Term Debt
492013
Quarters > 0 > balance Sheet > long Term Debt
-
Quarters > 0 > balance Sheet > total Liabilities
2148766
Quarters > 0 > balance Sheet > equity
1394161
Quarters > 0 > balance Sheet > currency_symbol
USD
Quarters > 0 > cash Flow > net Income
-2347302
Quarters > 0 > cash Flow > depreciation
1008
Quarters > 0 > cash Flow > change In Working Capital
-467322
Quarters > 0 > cash Flow > cash From Operations
-2626654
Quarters > 0 > cash Flow > capital Expenditures
4
Quarters > 0 > cash Flow > cash From Investing
-
Quarters > 0 > cash Flow > cash From Financing
-96375
Quarters > 0 > cash Flow > net Change In Cash
-2723029
Quarters > 0 > cash Flow > currency_symbol
USD
Quarters > 0 > ratios > PE
-1.050881740648714
Quarters > 0 > ratios > PB
2.371176643156709
Quarters > 0 > ratios > ROE
-168.3666377125741
Quarters > 0 > ratios > ROA
-66.25318557226836
Quarters > 0 > ratios > FCF
-2626658
Quarters > 0 > ratios > Piotroski FScore
0
Quarters > 0 > ratios > fcf Percent
-
Quarters > 0 > health Score
32
Quarters > 1 > quarter
2025-06-30
Quarters > 1 > income Statement > revenue
0
Quarters > 1 > income Statement > cost Of Revenue
-
Quarters > 1 > income Statement > gross Profit
-
Quarters > 1 > income Statement > operating Expenses
3910406
Quarters > 1 > income Statement > operating Income
-3910406
Quarters > 1 > income Statement > interest Expense
21743
Quarters > 1 > income Statement > pretax Income
-3706465
Quarters > 1 > income Statement > net Income
-3706465
Quarters > 1 > income Statement > eps
-3.291551737305671
Quarters > 1 > income Statement > dividends Per Share
0
Quarters > 1 > income Statement > shares Outstanding
1126054
Quarters > 1 > income Statement > income Tax Expense
-
Quarters > 1 > income Statement > EBITDA
-3910391
Quarters > 1 > income Statement > operating Margin
-
Quarters > 1 > income Statement > total Other Income Expense Net
203941
Quarters > 1 > income Statement > currency_symbol
USD
Quarters > 1 > balance Sheet > cash
4817672
Quarters > 1 > balance Sheet > short Term Investments
-
Quarters > 1 > balance Sheet > receivables
-
Quarters > 1 > balance Sheet > inventories
-
Quarters > 1 > balance Sheet > total Current Assets
5191917
Quarters > 1 > balance Sheet > property Plant Equipment
264025
Quarters > 1 > balance Sheet > total Assets
5504429
Quarters > 1 > balance Sheet > payables
1174374
Quarters > 1 > balance Sheet > short Term Debt
517822
Quarters > 1 > balance Sheet > long Term Debt
-
Quarters > 1 > balance Sheet > total Liabilities
1898910
Quarters > 1 > balance Sheet > equity
3605519
Quarters > 1 > balance Sheet > currency_symbol
USD
Quarters > 1 > cash Flow > net Income
-3706465
Quarters > 1 > cash Flow > depreciation
-979
Quarters > 1 > cash Flow > change In Working Capital
537068
Quarters > 1 > cash Flow > cash From Operations
-3355055
Quarters > 1 > cash Flow > capital Expenditures
0
Quarters > 1 > cash Flow > cash From Investing
-
Quarters > 1 > cash Flow > cash From Financing
3660120
Quarters > 1 > cash Flow > net Change In Cash
305065
Quarters > 1 > cash Flow > currency_symbol
USD
Quarters > 1 > ratios > PE
-3.291551737305671
Quarters > 1 > ratios > PB
0.4622246949745654
Quarters > 1 > ratios > ROE
-102.79976336277801
Quarters > 1 > ratios > ROA
-67.33604884357669
Quarters > 1 > ratios > FCF
-3355055
Quarters > 1 > ratios > Piotroski FScore
1
Quarters > 1 > ratios > fcf Percent
-
Quarters > 1 > health Score
38
Quarters > 2 > quarter
2025-03-31
Quarters > 2 > income Statement > revenue
0
Quarters > 2 > income Statement > cost Of Revenue
1008
Quarters > 2 > income Statement > gross Profit
-1008
Quarters > 2 > income Statement > operating Expenses
2951241
Quarters > 2 > income Statement > operating Income
-2951241
Quarters > 2 > income Statement > interest Expense
11930
Quarters > 2 > income Statement > pretax Income
-3053007
Quarters > 2 > income Statement > net Income
-3053007
Quarters > 2 > income Statement > eps
-0.748916183641775
Quarters > 2 > income Statement > dividends Per Share
0
Quarters > 2 > income Statement > shares Outstanding
4076567
Quarters > 2 > income Statement > income Tax Expense
-
Quarters > 2 > income Statement > EBITDA
-3040069
Quarters > 2 > income Statement > operating Margin
-
Quarters > 2 > income Statement > total Other Income Expense Net
-101766
Quarters > 2 > income Statement > currency_symbol
USD
Quarters > 2 > balance Sheet > cash
4512607
Quarters > 2 > balance Sheet > short Term Investments
-
Quarters > 2 > balance Sheet > receivables
-
Quarters > 2 > balance Sheet > inventories
-
Quarters > 2 > balance Sheet > total Current Assets
4959397
Quarters > 2 > balance Sheet > property Plant Equipment
278913
Quarters > 2 > balance Sheet > total Assets
5310190
Quarters > 2 > balance Sheet > payables
896885
Quarters > 2 > balance Sheet > short Term Debt
884084
Quarters > 2 > balance Sheet > long Term Debt
-
Quarters > 2 > balance Sheet > total Liabilities
2024925
Quarters > 2 > balance Sheet > equity
3285265
Quarters > 2 > balance Sheet > currency_symbol
USD
Quarters > 2 > cash Flow > net Income
-3053007
Quarters > 2 > cash Flow > depreciation
1008
Quarters > 2 > cash Flow > change In Working Capital
-77286
Quarters > 2 > cash Flow > cash From Operations
-2526924
Quarters > 2 > cash Flow > capital Expenditures
0
Quarters > 2 > cash Flow > cash From Investing
-
Quarters > 2 > cash Flow > cash From Financing
5119387
Quarters > 2 > cash Flow > net Change In Cash
2592463
Quarters > 2 > cash Flow > currency_symbol
USD
Quarters > 2 > ratios > PE
-0.748916183641775
Quarters > 2 > ratios > PB
1.8364786889337694
Quarters > 2 > ratios > ROE
-92.93031155781954
Quarters > 2 > ratios > ROA
-57.493366527374725
Quarters > 2 > ratios > FCF
-2526924
Quarters > 2 > ratios > Piotroski FScore
1
Quarters > 2 > ratios > fcf Percent
-
Quarters > 2 > health Score
39
Quarters > 3 > quarter
2024-12-31
Quarters > 3 > income Statement > revenue
5748
Quarters > 3 > income Statement > cost Of Revenue
1796
Quarters > 3 > income Statement > gross Profit
-1796
Quarters > 3 > income Statement > operating Expenses
1775332
Quarters > 3 > income Statement > operating Income
-1777128
Quarters > 3 > income Statement > interest Expense
159281
Quarters > 3 > income Statement > pretax Income
-1598469
Quarters > 3 > income Statement > net Income
-1598469
Quarters > 3 > income Statement > eps
-0.3921115487614947
Quarters > 3 > income Statement > dividends Per Share
-
Quarters > 3 > income Statement > shares Outstanding
4076567
Quarters > 3 > income Statement > income Tax Expense
-
Quarters > 3 > income Statement > EBITDA
-1437394
Quarters > 3 > income Statement > operating Margin
-30917.32776617954
Quarters > 3 > income Statement > total Other Income Expense Net
178659
Quarters > 3 > income Statement > currency_symbol
USD
Quarters > 3 > balance Sheet > cash
1920144
Quarters > 3 > balance Sheet > short Term Investments
0
Quarters > 3 > balance Sheet > receivables
-
Quarters > 3 > balance Sheet > inventories
-
Quarters > 3 > balance Sheet > total Current Assets
2210917
Quarters > 3 > balance Sheet > property Plant Equipment
295373
Quarters > 3 > balance Sheet > total Assets
2506290
Quarters > 3 > balance Sheet > payables
596600
Quarters > 3 > balance Sheet > short Term Debt
935384
Quarters > 3 > balance Sheet > long Term Debt
-
Quarters > 3 > balance Sheet > total Liabilities
1797138
Quarters > 3 > balance Sheet > equity
709152
Quarters > 3 > balance Sheet > currency_symbol
USD
Quarters > 3 > cash Flow > net Income
-1598469
Quarters > 3 > cash Flow > depreciation
1796
Quarters > 3 > cash Flow > change In Working Capital
-940136
Quarters > 3 > cash Flow > cash From Operations
-2690162
Quarters > 3 > cash Flow > capital Expenditures
2
Quarters > 3 > cash Flow > cash From Investing
2912849235
Quarters > 3 > cash Flow > cash From Financing
4453650
Quarters > 3 > cash Flow > net Change In Cash
1763488
Quarters > 3 > cash Flow > currency_symbol
USD
Quarters > 3 > ratios > PE
-0.3921115487614947
Quarters > 3 > ratios > PB
8.507794041333876
Quarters > 3 > ratios > ROE
-225.40569581697576
Quarters > 3 > ratios > ROA
-63.778293812767075
Quarters > 3 > ratios > FCF
-2690164
Quarters > 3 > ratios > Piotroski FScore
0
Quarters > 3 > ratios > fcf Percent
-468.01739735560193
Quarters > 3 > health Score
12
Annuals > 0 > quarter
2024-12-31
Annuals > 0 > income Statement > revenue
0
Annuals > 0 > income Statement > cost Of Revenue
5463
Annuals > 0 > income Statement > gross Profit
-5463
Annuals > 0 > income Statement > operating Expenses
7696170
Annuals > 0 > income Statement > operating Income
-7696170
Annuals > 0 > income Statement > interest Expense
1360156
Annuals > 0 > income Statement > pretax Income
-9144797
Annuals > 0 > income Statement > net Income
-9144797
Annuals > 0 > income Statement > eps
-0.8857334854497733
Annuals > 0 > income Statement > dividends Per Share
-
Annuals > 0 > income Statement > shares Outstanding
10324547
Annuals > 0 > income Statement > income Tax Expense
-
Annuals > 0 > income Statement > EBITDA
-7779178
Annuals > 0 > income Statement > operating Margin
-
Annuals > 0 > income Statement > total Other Income Expense Net
-1448627
Annuals > 0 > income Statement > currency_symbol
USD
Annuals > 0 > balance Sheet > cash
1920144
Annuals > 0 > balance Sheet > short Term Investments
2887215
Annuals > 0 > balance Sheet > receivables
14901
Annuals > 0 > balance Sheet > inventories
-
Annuals > 0 > balance Sheet > total Current Assets
2210917
Annuals > 0 > balance Sheet > property Plant Equipment
295373
Annuals > 0 > balance Sheet > total Assets
2506290
Annuals > 0 > balance Sheet > payables
596600
Annuals > 0 > balance Sheet > short Term Debt
935384
Annuals > 0 > balance Sheet > long Term Debt
-
Annuals > 0 > balance Sheet > total Liabilities
1797138
Annuals > 0 > balance Sheet > equity
709152
Annuals > 0 > balance Sheet > currency_symbol
USD
Annuals > 0 > cash Flow > net Income
-9144797
Annuals > 0 > cash Flow > depreciation
5463
Annuals > 0 > cash Flow > change In Working Capital
138911
Annuals > 0 > cash Flow > cash From Operations
-7327230
Annuals > 0 > cash Flow > capital Expenditures
19046
Annuals > 0 > cash Flow > cash From Investing
2915765
Annuals > 0 > cash Flow > cash From Financing
3755193
Annuals > 0 > cash Flow > net Change In Cash
-656272
Annuals > 0 > cash Flow > currency_symbol
USD
Annuals > 0 > ratios > PE
-0.8857334854497733
Annuals > 0 > ratios > PB
28.68123842279229
Annuals > 0 > ratios > ROE
-1289.5397601642526
Annuals > 0 > ratios > ROA
-364.8738573748449
Annuals > 0 > ratios > FCF
-7346276
Annuals > 0 > ratios > Piotroski FScore
0
Annuals > 0 > ratios > fcf Percent
-
Annuals > 0 > health Score
12
Annuals > 1 > quarter
2023-12-31
Annuals > 1 > income Statement > revenue
0
Annuals > 1 > income Statement > cost Of Revenue
6811
Annuals > 1 > income Statement > gross Profit
-6811
Annuals > 1 > income Statement > operating Expenses
5892382
Annuals > 1 > income Statement > operating Income
-5892382
Annuals > 1 > income Statement > interest Expense
2595263
Annuals > 1 > income Statement > pretax Income
-6592723
Annuals > 1 > income Statement > net Income
-6592723
Annuals > 1 > income Statement > eps
-0.41446032552816364
Annuals > 1 > income Statement > dividends Per Share
-
Annuals > 1 > income Statement > shares Outstanding
15906765
Annuals > 1 > income Statement > income Tax Expense
-1
Annuals > 1 > income Statement > EBITDA
-3990649
Annuals > 1 > income Statement > operating Margin
-
Annuals > 1 > income Statement > total Other Income Expense Net
-700341
Annuals > 1 > income Statement > currency_symbol
USD
Annuals > 1 > balance Sheet > cash
2576416
Annuals > 1 > balance Sheet > short Term Investments
2887215
Annuals > 1 > balance Sheet > receivables
14901
Annuals > 1 > balance Sheet > inventories
-
Annuals > 1 > balance Sheet > total Current Assets
5593005
Annuals > 1 > balance Sheet > property Plant Equipment
358731
Annuals > 1 > balance Sheet > total Assets
5951736
Annuals > 1 > balance Sheet > payables
283306
Annuals > 1 > balance Sheet > short Term Debt
648478
Annuals > 1 > balance Sheet > long Term Debt
135089
Annuals > 1 > balance Sheet > total Liabilities
1895965
Annuals > 1 > balance Sheet > equity
4055771
Annuals > 1 > balance Sheet > currency_symbol
USD
Annuals > 1 > cash Flow > net Income
-6592723
Annuals > 1 > cash Flow > depreciation
6811
Annuals > 1 > cash Flow > change In Working Capital
220634
Annuals > 1 > cash Flow > cash From Operations
-5581147
Annuals > 1 > cash Flow > capital Expenditures
19046
Annuals > 1 > cash Flow > cash From Investing
-2829723
Annuals > 1 > cash Flow > cash From Financing
2570083
Annuals > 1 > cash Flow > net Change In Cash
-5840787
Annuals > 1 > cash Flow > currency_symbol
USD
Annuals > 1 > ratios > PE
-0.41446032552816364
Annuals > 1 > ratios > PB
7.726355124586668
Annuals > 1 > ratios > ROE
-162.55165787220236
Annuals > 1 > ratios > ROA
-110.76974852379205
Annuals > 1 > ratios > FCF
-5600193
Annuals > 1 > ratios > Piotroski FScore
0
Annuals > 1 > ratios > fcf Percent
-
Annuals > 1 > health Score
26
Annuals > 2 > quarter
2022-12-31
Annuals > 2 > income Statement > revenue
0
Annuals > 2 > income Statement > cost Of Revenue
5972
Annuals > 2 > income Statement > gross Profit
-5972
Annuals > 2 > income Statement > operating Expenses
2337854
Annuals > 2 > income Statement > operating Income
-2343826
Annuals > 2 > income Statement > interest Expense
670610
Annuals > 2 > income Statement > pretax Income
-4996069
Annuals > 2 > income Statement > net Income
-4996069
Annuals > 2 > income Statement > eps
-0.4826632013808073
Annuals > 2 > income Statement > dividends Per Share
402068
Annuals > 2 > income Statement > shares Outstanding
10351046
Annuals > 2 > income Statement > income Tax Expense
71009
Annuals > 2 > income Statement > EBITDA
-4319487
Annuals > 2 > income Statement > operating Margin
-
Annuals > 2 > income Statement > total Other Income Expense Net
-2652243
Annuals > 2 > income Statement > currency_symbol
USD
Annuals > 2 > balance Sheet > cash
8417203
Annuals > 2 > balance Sheet > short Term Investments
0
Annuals > 2 > balance Sheet > receivables
-
Annuals > 2 > balance Sheet > inventories
-
Annuals > 2 > balance Sheet > total Current Assets
8578351
Annuals > 2 > balance Sheet > property Plant Equipment
68714
Annuals > 2 > balance Sheet > total Assets
8653545
Annuals > 2 > balance Sheet > payables
129245
Annuals > 2 > balance Sheet > short Term Debt
748296
Annuals > 2 > balance Sheet > long Term Debt
-
Annuals > 2 > balance Sheet > total Liabilities
975676
Annuals > 2 > balance Sheet > equity
7677869
Annuals > 2 > balance Sheet > currency_symbol
USD
Annuals > 2 > cash Flow > net Income
-3028448
Annuals > 2 > cash Flow > depreciation
66832
Annuals > 2 > cash Flow > change In Working Capital
-555205
Annuals > 2 > cash Flow > cash From Operations
-2710454
Annuals > 2 > cash Flow > capital Expenditures
0
Annuals > 2 > cash Flow > cash From Investing
-
Annuals > 2 > cash Flow > cash From Financing
10622908
Annuals > 2 > cash Flow > net Change In Cash
7912454
Annuals > 2 > cash Flow > currency_symbol
USD
Annuals > 2 > ratios > PE
-0.4826632013808073
Annuals > 2 > ratios > PB
2.6558880621693337
Annuals > 2 > ratios > ROE
-65.0710372891228
Annuals > 2 > ratios > ROA
-57.73436204468805
Annuals > 2 > ratios > FCF
-2710454
Annuals > 2 > ratios > Piotroski FScore
0
Annuals > 2 > ratios > fcf Percent
-
Annuals > 2 > health Score
34
Annuals > 3 > quarter
2021-12-31
Annuals > 3 > income Statement > revenue
0
Annuals > 3 > income Statement > cost Of Revenue
60834
Annuals > 3 > income Statement > gross Profit
-60834
Annuals > 3 > income Statement > operating Expenses
1682158
Annuals > 3 > income Statement > operating Income
-1742992
Annuals > 3 > income Statement > interest Expense
50788
Annuals > 3 > income Statement > pretax Income
-1152134
Annuals > 3 > income Statement > net Income
-1152134
Annuals > 3 > income Statement > eps
-0.08480057952099575
Annuals > 3 > income Statement > dividends Per Share
-
Annuals > 3 > income Statement > shares Outstanding
13586393
Annuals > 3 > income Statement > income Tax Expense
50788
Annuals > 3 > income Statement > EBITDA
-1040512
Annuals > 3 > income Statement > operating Margin
-
Annuals > 3 > income Statement > total Other Income Expense Net
590858
Annuals > 3 > income Statement > currency_symbol
USD
Annuals > 3 > balance Sheet > cash
504749
Annuals > 3 > balance Sheet > short Term Investments
-
Annuals > 3 > balance Sheet > receivables
0
Annuals > 3 > balance Sheet > inventories
-
Annuals > 3 > balance Sheet > total Current Assets
509615
Annuals > 3 > balance Sheet > property Plant Equipment
135546
Annuals > 3 > balance Sheet > total Assets
651641
Annuals > 3 > balance Sheet > payables
828313
Annuals > 3 > balance Sheet > short Term Debt
916435
Annuals > 3 > balance Sheet > long Term Debt
-
Annuals > 3 > balance Sheet > total Liabilities
2279773
Annuals > 3 > balance Sheet > equity
-1628132
Annuals > 3 > balance Sheet > currency_symbol
USD
Annuals > 3 > cash Flow > net Income
-1152134
Annuals > 3 > cash Flow > depreciation
60834
Annuals > 3 > cash Flow > change In Working Capital
519154
Annuals > 3 > cash Flow > cash From Operations
-300336
Annuals > 3 > cash Flow > capital Expenditures
4
Annuals > 3 > cash Flow > cash From Investing
-
Annuals > 3 > cash Flow > cash From Financing
687932
Annuals > 3 > cash Flow > net Change In Cash
387596
Annuals > 3 > cash Flow > currency_symbol
USD
Annuals > 3 > ratios > PE
-0.08480057952099575
Annuals > 3 > ratios > PB
-16.439204075590922
Annuals > 3 > ratios > ROE
70.76416408497592
Annuals > 3 > ratios > ROA
-176.80501994196192
Annuals > 3 > ratios > FCF
-300340
Annuals > 3 > ratios > Piotroski FScore
1
Annuals > 3 > ratios > fcf Percent
-
Annuals > 3 > health Score
31
Valuation > metrics > PE
-1.050881740648714
Valuation > metrics > PB
2.371176643156709
Valuation > final Score
80
Valuation > verdict
Fair
Profitability > metrics > ROE
-168.3666377125741
Profitability > metrics > ROA
-71.8727657472811
Profitability > final Score
15
Profitability > verdict
Weak
Risk > metrics > Debt Equity
1.5412610164823144
Risk > metrics > Interest Coverage
-119.91864155734235
Risk > final Score
-450
Risk > verdict
High
Liquidity > metrics > Current Ratio
1.6621183667445327
Liquidity > metrics > Quick Ratio
1.6621183667445327
Liquidity > final Score
92
Liquidity > verdict
Great
Prev Valuations > 0
70
Prev Valuations > 1
80
Prev Valuations > 2
20
Prev Profitabilities > 0
15
Prev Profitabilities > 1
15
Prev Profitabilities > 2
0
Prev Risks > 0
-671
Prev Risks > 1
-942
Prev Risks > 2
-27
Prev Liquidities > 0
100
Prev Liquidities > 1
100
Prev Liquidities > 2
86
Updated At
2026-01-20T22:34:03.976Z
Earnings History > 0 > period
2025-09-30
Earnings History > 0 > report Date
2025-11-13
Earnings History > 0 > date
2025-09-30
Earnings History > 0 > before After Market
-
Earnings History > 0 > currency
-
Earnings History > 0 > eps Actual
-1.05
Earnings History > 0 > eps Estimate
-
Earnings History > 0 > eps Difference
0
Earnings History > 0 > surprise Percent
-
Earnings History > 1 > period
2025-06-30
Earnings History > 1 > report Date
2025-08-13
Earnings History > 1 > date
2025-06-30
Earnings History > 1 > before After Market
-
Earnings History > 1 > currency
-
Earnings History > 1 > eps Actual
-3.29
Earnings History > 1 > eps Estimate
-
Earnings History > 1 > eps Difference
0
Earnings History > 1 > surprise Percent
-
Earnings History > 2 > period
2025-03-31
Earnings History > 2 > report Date
2025-05-08
Earnings History > 2 > date
2025-03-31
Earnings History > 2 > before After Market
-
Earnings History > 2 > currency
-
Earnings History > 2 > eps Actual
-7.6
Earnings History > 2 > eps Estimate
-
Earnings History > 2 > eps Difference
0
Earnings History > 2 > surprise Percent
-
Earnings History > 3 > period
2024-12-31
Earnings History > 3 > report Date
2025-02-26
Earnings History > 3 > date
2024-12-31
Earnings History > 3 > before After Market
-
Earnings History > 3 > currency
-
Earnings History > 3 > eps Actual
-0.4
Earnings History > 3 > eps Estimate
-
Earnings History > 3 > eps Difference
0
Earnings History > 3 > surprise Percent
-
Earnings History > 4 > period
2024-09-30
Earnings History > 4 > report Date
2024-09-30
Earnings History > 4 > date
2024-09-30
Earnings History > 4 > before After Market
-
Earnings History > 4 > currency
USD
Earnings History > 4 > eps Actual
-39.6791
Earnings History > 4 > eps Estimate
-
Earnings History > 4 > eps Difference
0
Earnings History > 4 > surprise Percent
-
Earnings History > 5 > period
2024-06-30
Earnings History > 5 > report Date
2024-06-30
Earnings History > 5 > date
2024-06-30
Earnings History > 5 > before After Market
-
Earnings History > 5 > currency
USD
Earnings History > 5 > eps Actual
-24.1245
Earnings History > 5 > eps Estimate
-
Earnings History > 5 > eps Difference
0
Earnings History > 5 > surprise Percent
-
Earnings History > 6 > period
2024-03-31
Earnings History > 6 > report Date
2024-03-31
Earnings History > 6 > date
2024-03-31
Earnings History > 6 > before After Market
-
Earnings History > 6 > currency
USD
Earnings History > 6 > eps Actual
-20.8483
Earnings History > 6 > eps Estimate
-
Earnings History > 6 > eps Difference
0
Earnings History > 6 > surprise Percent
-
Earnings History > 7 > period
2023-12-31
Earnings History > 7 > report Date
2023-12-31
Earnings History > 7 > date
2023-12-31
Earnings History > 7 > before After Market
-
Earnings History > 7 > currency
USD
Earnings History > 7 > eps Actual
-20.4175
Earnings History > 7 > eps Estimate
-
Earnings History > 7 > eps Difference
0
Earnings History > 7 > surprise Percent
-
Earnings History > 8 > period
2023-09-30
Earnings History > 8 > report Date
2023-09-30
Earnings History > 8 > date
2023-09-30
Earnings History > 8 > before After Market
-
Earnings History > 8 > currency
USD
Earnings History > 8 > eps Actual
-22.7735
Earnings History > 8 > eps Estimate
-
Earnings History > 8 > eps Difference
0
Earnings History > 8 > surprise Percent
-
Earnings History > 9 > period
2023-06-30
Earnings History > 9 > report Date
2023-06-30
Earnings History > 9 > date
2023-06-30
Earnings History > 9 > before After Market
-
Earnings History > 9 > currency
USD
Earnings History > 9 > eps Actual
-30.6335
Earnings History > 9 > eps Estimate
-
Earnings History > 9 > eps Difference
0
Earnings History > 9 > surprise Percent
-
Earnings History > 10 > period
2023-03-31
Earnings History > 10 > report Date
2023-03-31
Earnings History > 10 > date
2023-03-31
Earnings History > 10 > before After Market
-
Earnings History > 10 > currency
USD
Earnings History > 10 > eps Actual
-14.3018
Earnings History > 10 > eps Estimate
-
Earnings History > 10 > eps Difference
0
Earnings History > 10 > surprise Percent
-
Earnings History > 11 > period
2022-12-31
Earnings History > 11 > report Date
2023-03-15
Earnings History > 11 > date
2022-12-31
Earnings History > 11 > before After Market
-
Earnings History > 11 > currency
USD
Earnings History > 11 > eps Actual
-0.06
Earnings History > 11 > eps Estimate
-
Earnings History > 11 > eps Difference
0
Earnings History > 11 > surprise Percent
-
Earnings History > 12 > period
2022-09-30
Earnings History > 12 > report Date
2022-11-14
Earnings History > 12 > date
2022-09-30
Earnings History > 12 > before After Market
-
Earnings History > 12 > currency
USD
Earnings History > 12 > eps Actual
-0.02
Earnings History > 12 > eps Estimate
-
Earnings History > 12 > eps Difference
0
Earnings History > 12 > surprise Percent
-
Earnings History > 13 > period
2022-06-30
Earnings History > 13 > report Date
2022-07-13
Earnings History > 13 > date
2022-06-30
Earnings History > 13 > before After Market
-
Earnings History > 13 > currency
USD
Earnings History > 13 > eps Actual
-0.05
Earnings History > 13 > eps Estimate
0
Earnings History > 13 > eps Difference
-0.05
Earnings History > 13 > surprise Percent
-
Earnings History > 14 > period
2017-09-30
Earnings History > 14 > report Date
2017-11-20
Earnings History > 14 > date
2017-09-30
Earnings History > 14 > before After Market
-
Earnings History > 14 > currency
USD
Earnings History > 14 > eps Actual
0
Earnings History > 14 > eps Estimate
0
Earnings History > 14 > eps Difference
0
Earnings History > 14 > surprise Percent
-
Earnings History > 15 > period
2017-06-30
Earnings History > 15 > report Date
2017-08-14
Earnings History > 15 > date
2017-06-30
Earnings History > 15 > before After Market
-
Earnings History > 15 > currency
USD
Earnings History > 15 > eps Actual
0
Earnings History > 15 > eps Estimate
0
Earnings History > 15 > eps Difference
0
Earnings History > 15 > surprise Percent
-
Earnings History > 16 > period
2017-03-31
Earnings History > 16 > report Date
2017-06-26
Earnings History > 16 > date
2017-03-31
Earnings History > 16 > before After Market
-
Earnings History > 16 > currency
USD
Earnings History > 16 > eps Actual
0
Earnings History > 16 > eps Estimate
0
Earnings History > 16 > eps Difference
0
Earnings History > 16 > surprise Percent
-
Earnings History > 17 > period
2016-09-30
Earnings History > 17 > report Date
2016-12-09
Earnings History > 17 > date
2016-09-30
Earnings History > 17 > before After Market
-
Earnings History > 17 > currency
USD
Earnings History > 17 > eps Actual
-0.01
Earnings History > 17 > eps Estimate
0
Earnings History > 17 > eps Difference
-0.01
Earnings History > 17 > surprise Percent
-
Shuttle Pharmaceuticals Holdings, Inc., a clinical stage pharmaceutical company, develops novel therapies to cure cancers. The company is developing Ropidoxuridine, an oral halogenated pyrimidine to treat patients with brain tumors and sarcomas; and SP-2-225, a pre-clinical class IIb product candidate that effects on the regulation of the immune system. It is also developing SP-1-303, a pre-clinical selective Class I HDAC for use in the treatment of ER positive breast cancers; and SP-1-161, a HDAC inhibitor that initiates the mutated in ataxia-telangiectasia response pathway. The company was founded in 2012 and is headquartered in Gaithersburg, Maryland.
Stock Price
$0.00
decrease compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/AWhat Does the Market Think About Shuttle Pharmaceuticals Holdings Inc? Benzinga
Read more →Showing 2 of 10
(Last Updated 2025-09-30)
Health Score
Price to Book Ratio (P/B)
-
High
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Very Low
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
Debt to Equity
-
Very Low
Low ≥ 1
High ≤ 0.3
* Institutions hold a combined 0.52% of the total shares of Shuttle Pharmaceuticals Inc
1.
UBS Group AG(0.3144%)
since
2025/06/30
2.
Fidelity Extended Market Index(0.1674%)
since
2025/07/31
3.
Fidelity Nasdaq Composite Index(0.0247%)
since
2025/07/31
4.
Tower Research Capital LLC(0.0115%)
since
2025/06/30
5.
Bank of America Corp(0.0003%)
since
2025/06/30
6.
Federation des caisses Desjardins du Quebec(0.0002%)
since
2025/06/30
7.
Barclays PLC(0%)
since
2025/03/31
8.
Geode Capital Management, LLC(0%)
since
2025/06/30
9.
Armistice Capital, LLC(0%)
since
2025/06/30
10.
TWO SIGMA SECURITIES, LLC(0%)
since
2025/06/30
11.
Citadel Advisors Llc(0%)
since
2025/06/30
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
Date
—
EPS Estimate
—
Date
2025-09-30
EPS Actual
-1.05
EPS Estimate
—
EPS Difference
0
Surprise Percent
0%
(Last Updated 2025-09-30)
(Last Updated 2025-09-30)
Revenue
$ 0
Cost Of Revenue
$ 0
Gross Profit
$ 0
Operating Expenses
$ 0
Operating Income
$ 0
Interest Expense
$ 0
Pretax Income
$ 0
Net Income
$ 0
Income Tax Expense
$ 0
EBITDA
$ 0
Total Other Income Expense Net
$ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2025-09-30)
Cash
$ 0
Short Term Investments
$ 0
Receivables
$ 0
Inventories
$ 0
Total Current Assets
$ 0
Property Plant Equipment
$ 0
Total Assets
$ 0
Payables
$ 0
Short Term Debt
$ 0
Long Term Debt
$ 0
Total Liabilities
$ 0
Equity
$ 0
(Last Updated 2025-09-30)
Net Income
$ 0
Depreciation
$ 0
Change In Working Capital
$ 0
Cash From Operations
$ 0
Capital Expenditures
$ 0
Cash From Investing
$ 0
Cash From Financing
$ 0
Net Change In Cash
$ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.